Oral manifestation of thrombocytopenia in immunosuppressed patient - Report of case
DOI:
https://doi.org/10.5935/2525-5711.20160008Keywords:
acquired immunodeficiency syndrome, lood platelets, platelet count, thrombocytopeniaAbstract
Thrombocytopenia (or thrombopenia) is a relative decrease of platelets in blood.This condition is associated with increased mortality rates in critically ill patients. It is especially present in cases of sepsis, but can also be caused by medications or associated with the use of foreign materials. Many physiological mechanisms (immune-mediated, consumption or destruction) are involved in the decrease of platelet count. This manuscript describes a case of severe thrombocytopenia with oral manifestation in immunosuppressed patient. A 39-year-old male was admitted to the Hospital Oswaldo Cruz complaining of bleeding in the lower lip. Epistaxis, crusts on the lips and red lesions in the hard palate were observed.
References
George JN. Platelets. Lancet 2000;355:1531-9. DOI: http://dx.doi.org/10.1016/S0140-6736(00)02175-9
Horrell CJ, Rothman J. The etiology of thrombocytopenia. Dimens Crit Care Nurs. 2001;20(4):10-6. DOI: http://dx.doi.org/10.1097/00003465-200107000-00004
Posadas MA, Hahn D, Schleuter W, Paparello J. Thrombocytopenia associated with dialysis treatments. Hemodial Int. 2011;15(3):416-23. DOI: http://dx.doi.org/10.1111/j.1542-4758.2011.00561.x
Konkle BA. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program. 2011;2011:391-6. PMID: 22160063 DOI: http://dx.doi.org/10.1182/asheducation-2011.1.391
Neville B, Damm DD, Allen CM, Bouqout J. Oral and Maxillofacial Pathology. 2nd ed. St. Louis: Saunders; 2002.
Patel AK,Thakrar SJ, Ghanchi FD. Clinical and laboratory profile of patients with TB/HIV coinfection: A case series of 50 patients. Lung India. 2011;28(2):93-6. DOI: http://dx.doi.org/10.4103/0970-2113.80316
Kaslow RA, Phair JP, Friedman HB, Lyter D, Solomon RE, Dudley J, et al. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. Ann Intern Med 1987;107(4):474-80.
Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol 1992;48(3):168-72. DOI: http://dx.doi.org/10.1111/j.1600-0609.1992.tb00591.x
Sogaard OS, Lohse N, Ostergaard L, Kronborg G, Roge B, Gerstoft J, et al. Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS One. 2012;7(3):e32538.
Vannappagari V, Nkhoma ET, Atashili J, Laurent SS, Zhao H. Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets. 2011;22(8):611-8. DOI: http://dx.doi.org/10.3109/09537104.2011.582526
Hassan AA, Kroll MH. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program. 2005:403-8. PMID: 16304411
Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost. 2005;3:775-7.
Murphy MF, Metcalfe P,Waters HA, Carne CA,Weller IV, Linch DC, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol. 1987;66:337-40.
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison's principles of internal medicine. 17a. Ed. New York: McGraw-Hill; 2008.
Ciernik IF, Cone RW, Fehr J,Weber R. Impaired liver function and retroviral activity are risk factors contributing to HIV-associated thrombocytopenia. Swiss HIV Cohort Study. AIDS. 1999;13(14):1913-20. PMID: 10513650 DOI: http://dx.doi.org/10.1097/00002030-199910010-00014
Firnhaber C, Smeaton L, Saukila N, Flanigan T, Gangakhedkar R, Kumwenda J, et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis. 2010;14(12):e1088-92. DOI: http://dx.doi.org/10.1016/j.ijid.2010.08.002
Guinat M,Vincent JL. Thrombocytopenia in the critically ill patient. Rev Med Brux. 2011;32(6):513-22.
Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia (ITP): the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012. (In press). DOI: http://dx.doi.org/10.1182/blood-2011-12-309153
Rarick MU, Espina B, Montgomery T, Easley A,Allen J, LevineAM. The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV. AIDS. 1991: 5(11):1357-61. PMID: 1768385 DOI: http://dx.doi.org/10.1097/00002030-199111000-00012
Aboulafia DM, Bundow D,Waide S, Bennet C, Kerr D. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia. Am J Med Sci. 2000;320(2):117-23. DOI: http://dx.doi.org/10.1097/00000441-200008000-00010
Liebman HA. Viral-associated immune thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2008:212-8. PMID: 19074085
Cines DB, Bussel JB, McMillan RB, Zehnder JL. Congenital and acquired thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2004:390-406. PMID: 15561694
